Onko BCG 100

Onko BCG 100
Product Description

BCG for immunotherapy.
The product is intended for treatment of superficial, epithelial non-invasive urothelial carcinomas (carcinoma urotheliale Ta, Tis, T1)

1 ampoule or 1 vial with the powder contains:
Live attenuated bacilli Bacillus Calmette-Guerin, Brazilian BCG Moreau substrain – 100 mg
1 ampoule or 1 vial of Onko BCG 100 contains not less than 300 million of live BCG.

Read more Show less

Synthaverse S.A.

  • PL
  • 2023
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    Immune Health
More specifications Fewer specifications
Sales Markets
Show more Show less

Synthaverse S.A.

  • PL
  • 2023
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
View company profile

More Products from Synthaverse S.A. (2)

  • Anti-tuberculosis vaccine BCG10

    Product Anti-tuberculosis vaccine BCG10

    BCG 10 Anti-Tuberculosis Vaccine is used for protective vaccinations against tuberculosis. Catch-up (supplementary) vaccinations in subjects unvaccinated after birth should be performed as early as possible, no later than at 15 years of age. In case of BCG immunisation booster vaccine doses are not recomme...
  • Distreptaza

    Product Distreptaza

    Rectal suppositories indicated for:

    1) Supportive treatment of pelvic inflammatory disease (PID) –  inflammatory diseases of the ovaries, fallopian tubes and endometrium,
    2) Adhesions after abdominal surgical procedures,
    3) Acute haemorrhoidal disease and chronic haemorr...